Retinal Flow Density Changes in Early-stage Parkinson’s Disease Investigated by Swept-Source Optical Coherence Tomography Angiography

References

• Langston JW. Epidemiology versus genetics in parkinson’s disease: progress in resolving an age-old debate. Ann Neurol. 1998;44(3 Suppl 1):S45–52. doi:https://doi.org/10.1002/ana.410440707.
   PubMed Web of Science ®Google Scholar
• Muhammed K, Manohar S, Husain M. Mechanisms underlying apathy in parkinson’s disease. Lancet. 2015;385(Suppl):1(S71. doi:https://doi.org/10.1016/S0140-6736(15)60386-5.
   PubMedGoogle Scholar
• Huang B, Wu S, Wang Z, Ge L, Rizak JD, Wu J, Li J, Xu L, Lv L, Yin Y, et al. Phosphorylated alpha-synuclein accumulations and lewy body-like pathology distributed in parkinson’s disease-related brain areas of aged rhesus monkeys treated with mptp. Neuroscience. 2018;379:302–15. doi:https://doi.org/10.1016/j.neuroscience.2018.03.026.
   PubMed Web of Science ®Google Scholar
• Blauwendraat C, Heilbron K, Vallerga CL, Bandres-Ciga S, Von Coelln R, Pihlstrom L, Simon-Sanchez J, Schulte C, Sharma M, Krohn L, et al. Parkinson’s disease age at onset genome-wide association study: defining heritability, genetic loci, and alpha-synuclein mechanisms. Mov Disord. 2019;34(6):866–75. doi:https://doi.org/10.1002/mds.27659.
   PubMed Web of Science ®Google Scholar
• Coulombre AJ. Experimental embryology of the vertebrate eye. Invest Ophthalmol. 1965;4:411–19.
   PubMedGoogle Scholar
• Davidsdottir S, Cronin-Golomb A, Lee A. Visual and spatial symptoms in parkinson’s disease. Vision Res. 2005;45(10):1285–96. doi:https://doi.org/10.1016/j.visres.2004.11.006.
   PubMed Web of Science ®Google Scholar
• Pilat A, McLean RJ, Proudlock FA, Maconachie GD, Sheth V, Rajabally YA, Gottlob I. In vivo morphology of the optic nerve and retina in patients with parkinson’s disease. Invest Ophthalmol Vis Sci. 2016;57(10):4420–27. doi:https://doi.org/10.1167/iovs.16-20020.
   PubMed Web of Science ®Google Scholar
• Bittersohl D, Stemplewitz B, Keseru M, Buhmann C, Richard G, Hassenstein A. Detection of retinal changes in idiopathic parkinson’s disease using high-resolution optical coherence tomography and heidelberg retina tomography. Acta Ophthalmol. 2015;93(7):e578–584. doi:https://doi.org/10.1111/aos.12757.
   PubMed Web of Science ®Google Scholar
• Kwapong WR, Ye H, Peng C, Zhuang X, Wang J, Shen M, Lu F. Retinal microvascular impairment in the early stages of parkinson’s disease. Invest Ophthalmol Vis Sci. 2018;59(10):4115–22. doi:https://doi.org/10.1167/iovs.17-23230.
   PubMed Web of Science ®Google Scholar
• Copete S, Flores-Moreno I, Montero JA, Duker JS, Ruiz-Moreno JM. Direct comparison of spectral-domain and swept-source oct in the measurement of choroidal thickness in normal eyes. British J Ophthalmol. 2014;98(3):334–38. doi:https://doi.org/10.1136/bjophthalmol-2013-303904.
   PubMed Web of Science ®Google Scholar
• Grulkowski I, Liu JJ, Zhang JY, Potsaid B, Jayaraman V, Cable AE, Duker JS, Fujimoto JG. Reproducibility of a long-range swept-source optical coherence tomography ocular biometry system and comparison with clinical biometers. Ophthalmology. 2013;120(11):2184–90. doi:https://doi.org/10.1016/j.ophtha.2013.04.007.
   PubMed Web of Science ®Google Scholar
• Lim L, Cheung G, Lee S. Comparison of spectral domain and swept-source optical coherence tomography in pathological myopia. Eye. 2014;28(4):488–91. doi:https://doi.org/10.1038/eye.2013.308.
   PubMed Web of Science ®Google Scholar
• Tan CS, Ngo WK, Cheong KX. Comparison of choroidal thicknesses using swept source and spectral domain optical coherence tomography in diseased and normal eyes. British J Ophthalmol. 2015;99(3):354–58. doi:https://doi.org/10.1136/bjophthalmol-2014-305331.
   PubMed Web of Science ®Google Scholar
• Kashani AH, Chen C-L, Gahm JK, Zheng F, Richter GM, Rosenfeld PJ, Shi Y, Wang RK. Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog Retin Eye Res. 2017;60:66–100.
   PubMed Web of Science ®Google Scholar
• Nagiel A, Sadda SR, Sarraf D. A promising future for optical coherence tomography angiography. JAMA Ophthalmol. 2015;133(6):629–30. doi:https://doi.org/10.1001/jamaophthalmol.2015.0668.
   PubMed Web of Science ®Google Scholar
• Yang J, Wang E, Yuan M, Chen Y. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography. Graefe’s Arch Clin Exp Ophthalmol. 2020;258(2):241–47. doi:https://doi.org/10.1007/s00417-019-04524-7.
   PubMed Web of Science ®Google Scholar
• Shen C, Li Y, Wang Q, Chen YN, Li W, Wei WB. Choroidal vascular changes in retinitis pigmentosa patients detected by optical coherence tomography angiography. BMC Ophthalmol. 2020;20(1):384. doi:https://doi.org/10.1186/s12886-020-01640-5.
   PubMed Web of Science ®Google Scholar
• Shi C, Chen Y, Kwapong WR, Tong Q, Wu S, Zhou Y, Miao H, Shen M, Ye H. Characterization by fractal dimension analysis of the retinal capillary network in parkinson disease. Retina. 2020;40(8):1483–91. doi:https://doi.org/10.1097/IAE.0000000000002641.
   PubMed Web of Science ®Google Scholar
• Rascuna C, Russo A, Terravecchia C, Castellino N, Avitabile T, Bonfiglio V, Fallico M, Chisari CG, Cicero CE, Grillo M, et al. Retinal thickness and microvascular pattern in early parkinson’s disease. Front Neurol. 2020;11:533375. doi:https://doi.org/10.3389/fneur.2020.533375.
   PubMed Web of Science ®Google Scholar
• Hirsch EC, Hunot S. Neuroinflammation in parkinson’s disease: a target for neuroprotection? Lancet Neurol. 2009;8(4):382–97. doi:https://doi.org/10.1016/S1474-4422(09)70062-6.
   PubMed Web of Science ®Google Scholar
• Tansey MG, Goldberg MS. Neuroinflammation in parkinson’s disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010;37(3):510–18. doi:https://doi.org/10.1016/j.nbd.2009.11.004.
   PubMed Web of Science ®Google Scholar
• Su X, Maguire-Zeiss KA, Giuliano R, Prifti L, Venkatesh K, Federoff HJ. Synuclein activates microglia in a model of parkinson’s disease. Neurobiol Aging. 2008;29(11):1690–701. doi:https://doi.org/10.1016/j.neurobiolaging.2007.04.006.
   PubMed Web of Science ®Google Scholar
• Farkas E, De Jong GI, De Vos RA, Jansen Steur EN, Luiten PG. Pathological features of cerebral cortical capillaries are doubled in alzheimer’s disease and parkinson’s disease. Acta Neuropathol. 2000;100(4):395–402. doi:https://doi.org/10.1007/s004010000195.
   PubMed Web of Science ®Google Scholar
• Ortuno-Lizaran I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N. Phosphorylated alpha-synuclein in the retina is a biomarker of parkinson’s disease pathology severity. Mov Disord. 2018;33(8):1315–24. doi:https://doi.org/10.1002/mds.27392.
   PubMed Web of Science ®Google Scholar
• Robbins CB, Thompson AC, Bhullar PK, Koo HY, Agrawal R, Soundararajan S, Yoon SP, Polascik BW, Scott BL, Grewal DS, et al. Characterization of retinal microvascular and choroidal structural changes in parkinson disease. JAMA Ophthalmol. 2021;139(2):182–88. doi:https://doi.org/10.1001/jamaophthalmol.2020.5730.
   PubMed Web of Science ®Google Scholar
• Yoneda S, Hara H, Hirata A, Fukushima M, Inomata Y, Tanihara H. Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol. 2005;49(2):106–08. doi:https://doi.org/10.1007/s10384-004-0156-x.
   PubMed Web of Science ®Google Scholar
• Ohayon A, Sacconi R, Semoun O, Corbelli E, Souied EH, Querques G. Choroidal neovascular area and vessel density comparison between two swept-source optical coherence tomography angiography devices. Retina. 2020;40(3):521–28. doi:https://doi.org/10.1097/IAE.0000000000002430.
   PubMed Web of Science ®Google Scholar
• Schneider M, Muller HP, Lauda F, Tumani H, Ludolph AC, Kassubek J, Pinkhardt EH. Retinal single-layer analysis in parkinsonian syndromes: An optical coherence tomography study. J Neural Transm (Vienna) 2014:121(1): 41–47.
   Google Scholar
• Zou J, Liu K, Li F, Xu Y, Shen L, Xu H. Combination of optical coherence tomography (oct) and oct angiography increases diagnostic efficacy of parkinson’s disease. Quant Imaging Med Surg. 2020;10(10):1930–39. doi:https://doi.org/10.21037/qims-20-460.
   PubMed Web of Science ®Google Scholar